VWM
AVXL icon

Vermillion Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Vermillion Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.14K Sell
2,000
-1,177
-37% -$5.1K ﹤0.01% 459
2025
Q4 		$11.3K Hold
3,177
– – ﹤0.01% 364
2025
Q3 		$28.3K Hold
3,177
– – 0.01% 753
2025
Q2 		$29.3K Hold
3,177
– – 0.01% 223
2025
Q1 		$27.3K Hold
3,177
– – 0.01% 640
2024
Q4 		$34.1K Buy
+3,177
New +$24.4K 0.02% 212

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM